Finance

Roʻyxatlar
Nega I1DX34 oshdi 2,93%?
Batafsil oʻrganish
I1DX34:BVMF
Idexx Laboratories Inc Bdr
531,51 R$
+2,93%
(+15,15) 1K
14-okt, 16:56:00 (GMT-3)  ·   BRL
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
I1DX34 tikeri uchun statistika yaratilmoqda...
Ochish
531,51 R$
Yuqori
531,51 R$
Past
531,51 R$
Bozor kapitali
41,68 mlrd
Oʻrtacha hajm
6,00
Hajmi
1,00
52 haftalik eng yuqori
813,60 R$
52 haftalik eng past
509,99 R$
Muomaladagi aksiyalar
78,78 mln
Xodimlar soni
11 ming
Ochish
531,51 R$
Yuqori
531,51 R$
Past
531,51 R$
Bozor kapitali
41,68 mlrd
Oʻrtacha hajm
6,00
Hajmi
1,00
52 haftalik eng yuqori
813,60 R$
52 haftalik eng past
509,99 R$
Muomaladagi aksiyalar
78,78 mln
Xodimlar soni
11 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions. In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO. In 2025, IDEXX estimated annual sales between $4.21 billion and $4.28 billion, with total quarterly revenue exceeding $1 billion. Wikipedia
Idexx Laboratories Inc Bdr haqida
CEOJay Mazelsky
Xodimlar soni11 ming
Asos solingan19-dek, 1983
Bosh ofislarWestbrook, Meyn, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytidexx.com
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar – USD
sen, 2025
dek, 2025
mar, 2026
iyn, 2026
Daromad
1,11 mlrd
1,09 mlrd
1,14 mlrd
1,22 mlrd
Sotilgan mahsulotning tannarxi
421,88 mln
432,46 mln
418,08 mln
437,50 mln
Daromad narxi
421,88 mln
432,46 mln
418,08 mln
437,50 mln
Tadqiqot va ishlanmalarga xarajatlar
63,42 mln
66,83 mln
65,79 mln
65,43 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
265,09 mln
266,68 mln
294,36 mln
288,09 mln
Operatsion xarajatlar
328,51 mln
333,51 mln
360,15 mln
353,52 mln
Jami operatsion xarajatlar
750,39 mln
765,97 mln
778,23 mln
791,02 mln
Operatsion daromad
354,85 mln
324,60 mln
362,59 mln
425,57 mln
Boshqa nooperatsion daromad
-
-
-
-
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
344,77 mln
306,98 mln
355,44 mln
417,22 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
344,77 mln
315,98 mln
355,44 mln
415,99 mln
Daromad soligʻi boʻyicha xarajat
70,16 mln
58,79 mln
77,00 mln
78,81 mln
Amaldagi soliq stavkasi
20,35%
19,15%
21,66%
18,89%
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
274,61 mln
248,19 mln
278,45 mln
338,41 mln
Sof foyda marjasi
24,85%
22,76%
24,41%
27,82%
Har bir aksiya foydasi
3,40
3,08
3,47
4,27
Foizlar va investitsiyalardan olingan daromadlar
580,00 ming
587,00 ming
597,00 ming
606,00 ming
Foizlarni toʻlash xarajatlari
-10,66 mln
-9,21 mln
-7,74 mln
-10,18 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
-10,08 mln
-8,62 mln
-7,14 mln
-9,58 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
391,47 mln
363,33 mln
400,27 mln
466,62 mln
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
AI kontentda xatolar boʻlishi mumkin. Batafsil
Google ilovalari